Literature DB >> 1291638

Isolation of plasma cholesterol-lowering components from ningyotake (Polyporus confluens) mushroom.

K Sugiyama1, H Kawagishi, A Tanaka, S Saeki, S Yoshida, H Sakamoto, Y Ishiguro.   

Abstract

The present study was undertaken to isolate component(s) which contributes to the hypocholesterolemic action of Ningyotake (Polyporus confluens) mushroom. The mushroom powder was extracted with 80% ethanol, and the extract and residue were fractionated into five fractions according to the solubility to solvents. When each fraction was added to a diet containing 1% cholesterol and 0.25% sodium cholate and fed to rats, the plasma cholesterol level was significantly decreased only by ethyl acetate-soluble fraction. Therefore, ethyl acetate-soluble fraction was further fractionated by silica gel column chromatography. Two major compounds, which comprised 45.0% and 28.5% of the ethyl acetate-soluble fraction, were obtained in a pure form by the chromatography, and the compounds were identified as grifolin (2-trans, trans-farnesyl-5-methylresorcinol) and neogrifolin (4-trans, trans-farnesyl-5-methylresorcinol), respectively. The addition of grifolin and neogrifolin to the high cholesterol diet was found to lower plasma cholesterol level significantly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291638     DOI: 10.3177/jnsv.38.335

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  2 in total

1.  Novel selective ligands for free fatty acid receptors GPR120 and GPR40.

Authors:  Takafumi Hara; Akira Hirasawa; Qi Sun; Keiko Sadakane; Chisato Itsubo; Tomoyo Iga; Tetsuya Adachi; Taka-aki Koshimizu; Toshihiro Hashimoto; Yoshinori Asakawa; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-27       Impact factor: 3.000

2.  Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.

Authors:  A Berger; D Rein; E Kratky; I Monnard; H Hajjaj; I Meirim; C Piguet-Welsch; J Hauser; K Mace; P Niederberger
Journal:  Lipids Health Dis       Date:  2004-02-18       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.